Angels Santé

MB Therapeutics is a pharmaceutical company specializing in personalized medicine. It offers a patient-centric system for developing and producing customized medications, including evaluation services. The company excels in tailoring medication dosage, forms, and combining multiple active ingredients into a single unit, enabling healthcare professionals to enhance treatment precision and improve patient adherence.

Sirius NeoSight is a biotechnology company developing healthcare technology to detect circulating tumor cells. Its patented method measures membrane fluidity, enabling early cancer diagnosis, monitoring treatment response, and adjusting therapies for aggressive and metastatic cancers.

Hephaistos Pharma is a biotechnology company developing an immunotherapy platform aimed at producing advanced oncology treatments. Its platform enhances commercialized antibodies by stimulating the immune system, turning 'cold' tumors into targets for immune response.

SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Abcely is a biotechnology company developing orally active immunoglobulin-based therapies for mucosal cancers and inflammatory conditions. Their innovative approach focuses on precision and non-invasiveness.

Odimma is a biotech company specializing in precision medicine aimed at developing personalized cancer immunotherapy solutions. The company has created an innovative immunotherapy drug that harnesses a unique platform, integrating three specific immune components designed to work together with the patient's immune system. When administered, this approach aims to induce and enhance immune responses, providing patients with the potential to eliminate tumors while minimizing adverse side effects. Through its focus on personalized treatment strategies, Odimma seeks to improve outcomes for cancer patients by tailoring therapies to individual needs.

Ensweet is a telemedicine platform specializing in telerehabilitation services aimed at enhancing patient accessibility to rehabilitation care. The company provides a range of equipment, including heart rate sensors and physical activity tools, allowing patients to engage in exercise regardless of their circumstances. This innovative approach ensures that rehabilitation is accessible to all, promoting healthier lifestyles and improved recovery outcomes for individuals in need of rehabilitation services.

Healshape is a biotech startup dedicated to developing natural breast reconstruction solutions for women through innovative regenerative medicine techniques. The company specializes in creating bioprostheses using 3D bioprinting technology, offering an alternative to traditional breast reconstruction methods. By focusing on natural products, Healshape aims to provide women with long-lasting, aesthetically pleasing results, helping them regain their self-confidence following surgery.

Vaxxel is a biotechnology company focused on developing live-attenuated vaccines. Its innovative platform aims to create novel vaccines targeting critical respiratory diseases such as bronchiolitis and pneumonia, specifically caused by human metapneumovirus.

Mapatho operates an online platform designed to help patients find healthcare professionals specializing in specific chronic pathologies. The platform aims to reduce post-diagnosis medical wandering by connecting patients with collaborative networks of health professionals, fostering solidarity among those living with chronic diseases.

Gaoma Therapeutics is a biotechnology company dedicated to developing therapeutic molecules for neurological and inflammatory diseases. Its initial candidate, GAO-3-02, is a proprietary active component targeting epilepsy and cognitive disorders, with potential applications in other areas.

OncoDiag is a biotechnology company based in Normandy, France, specializing in the development of non-invasive diagnostic tests aimed at the early detection of cancers. Its flagship product, Urotest, is a urine test designed for the diagnosis and monitoring of bladder cancer. Additionally, the company is advancing its pipeline with Colodiag, which focuses on the early detection of colorectal cancer. OncoDiag's portfolio also includes a tissue-based test for predicting non-evolutive localized prostate cancer. By offering these innovative diagnostic solutions, OncoDiag aims to enhance the capabilities of healthcare professionals in cancer diagnosis and management.

Omini develops a portable, multiplex biosensor platform for blood testing that enables the simultaneous detection of multiple biomarkers. The device is designed for chronic disease monitoring and therapy management, providing personalized biomarker data to adjust treatments and help prevent acute crises, with applications for general practitioners. Incorporated in 2019 and based in Saint-Mandé, France, Omini aims to offer a low-cost, regular monitoring solution that supports routine assessment of complex conditions such as heart failure.

Braintale develops and distributes digital tools for diagnosing and prognosing brain injuries. Its platform analyzes magnetic resonance imaging reports to help healthcare professionals predict patient trajectories, including the likelihood of coma and the need for intensive care after severe traumatic brain injury, cardiac arrest, or hemorrhagic stroke. Built on more than 15 years of clinical development, the company aims to translate medical insights into accessible decision-support for hospitals and patients. Founded in 2018 and based in Paris, France, Braintale focuses on improving neurological care through evidence-based, easy-to-use digital solutions.

GoSense is a company that specializes in developing innovative sensory enhancement technologies aimed at improving the mobility and independence of visually impaired individuals. The company has created solutions that include a sound-based GPS and travel assistant, which utilizes spatialized sound to help users navigate their environment. Additionally, GoSense offers a smart sensory device designed to detect obstacles, reducing the risk of injury while traveling. Their products also feature outside-the-ear headphones that allow users to remain aware of their surroundings, promoting safe travel without reliance on others. Through these advancements, GoSense aims to augment human perception and empower visually impaired persons to navigate their world more confidently.

SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Hillo is a France-based company that designs and operates an artificial intelligence powered platform for diabetes management. The platform supports continuous glucose monitoring, provides real-time glycemia predictions, and offers case-specific treatment guidance. It adapts to individual patients, synchronizes with an insulin delivery device, logs treatment history, and analyzes meal intake alongside behavioral and physiological responses to improve glucose control. Founded in 2016 and headquartered in Palaiseau, Hillo serves the medical industry with tools for clinicians and patients to manage diabetes more effectively.

Primaa is a MedTech company that provides an AI-powered platform for automated cancer diagnosis. Through image analysis and deep learning, the software enhances the detection of cancer biomarkers and supports personalized treatment decisions. It offers digital histology capabilities that digitize tissue slides, aggregate images in a database, and enable digital identification of tissue anomalies. The platform aims to increase diagnostic accuracy and throughput while maintaining consistent reliability across histological assessments.

Wefight Inc. is a technology company focused on enhancing patient care within the healthcare sector. Founded in 2017 and based in Montpellier, France, the company has developed a virtual medical assistance platform, including an application called Vik-Sein, which specifically targets breast cancer patients. The application provides vital support by answering patient inquiries, sending reminders for medication adherence, and facilitating the discovery of relevant clinical trials. Additionally, Wefight's platform enables patients to monitor side effects and share health data with their healthcare providers, thereby improving the overall patient experience and enabling clinicians to better understand and manage patients' conditions between visits. By providing these services, Wefight aims to empower patients to manage their health from home while optimizing the time and effectiveness of care teams.

SentinHealth is a life science company specializing in integrated care solutions designed to monitor and prevent the deterioration of chronic illnesses, particularly heart failure. The company develops advanced telemonitoring technology that includes an implant connected to the cloud, providing daily health status updates and predictive insights. This system focuses on early detection of acute decompensated heart failure (ADHF) by monitoring daily heart activity and other indicators from the digestive system, allowing for timely interventions before hospitalization becomes necessary. SentinHealth addresses the critical needs of patients requiring continuous automated monitoring, ultimately aiming to enhance patient outcomes in the management of serious chronic conditions.

OncoDiag is a biotechnology company based in Normandy, France, specializing in the development of non-invasive diagnostic tests aimed at the early detection of cancers. Its flagship product, Urotest, is a urine test designed for the diagnosis and monitoring of bladder cancer. Additionally, the company is advancing its pipeline with Colodiag, which focuses on the early detection of colorectal cancer. OncoDiag's portfolio also includes a tissue-based test for predicting non-evolutive localized prostate cancer. By offering these innovative diagnostic solutions, OncoDiag aims to enhance the capabilities of healthcare professionals in cancer diagnosis and management.

C4Diagnostics is a developer of in vitro diagnostic (IVD) kits that leverages proprietary technology to enhance the speed and sensitivity of diagnostic testing. The company focuses on creating medical devices and equipment that streamline the screening process for urinary tract infections, allowing for the reliable detection, counting, and concentration of relevant microorganisms in clinical microbiology. By enabling hospitals and laboratories to conduct culture-based IVD tests and specific fluorescence assessments, C4Diagnostics contributes to more efficient and effective diagnostic practices in healthcare settings.

Founded in 2014 through a collaboration between experts from the Langevin Institute and Georges Pompidou Hospital, Cardiawave develops non-invasive ultrasonic medical devices for treating heart valve diseases. Its flagship product uses real-time imaging and ultrasound technology to treat conditions like calcified aortic stenosis without thermal injury or invasive procedures.

PREMEDIT SAS is a company based in Loos, France, that specializes in the design and development of application software under the brand name Running Care. This software is aimed at runners, providing tools to predict, prevent, and manage pain and injuries through the use of artificial intelligence to monitor their health. Running Care is classified as a class I medical device for the diagnosis and rehabilitation of running-related injuries and carries the CE marking, indicating compliance with health regulations. In addition to its core functionalities, the software offers features such as integration with other running apps, affiliation with sports and healthcare products, a content platform for non-healthcare professionals, sports medicine data analysis, and promotional activities related to sports and health issues. Founded in 2016, PREMEDIT is committed to enhancing the well-being of runners through innovative technological solutions.

Hillo is a France-based company that designs and operates an artificial intelligence powered platform for diabetes management. The platform supports continuous glucose monitoring, provides real-time glycemia predictions, and offers case-specific treatment guidance. It adapts to individual patients, synchronizes with an insulin delivery device, logs treatment history, and analyzes meal intake alongside behavioral and physiological responses to improve glucose control. Founded in 2016 and headquartered in Palaiseau, Hillo serves the medical industry with tools for clinicians and patients to manage diabetes more effectively.

Auxivia, established in 2015 and headquartered in Paris, France, specializes in designing and developing smart glasses connected to an online platform. These glasses, indistinguishable from regular ones, track water intake and alert users to prevent dehydration. The company's innovative solution aims to enhance caregiving quality for elderly individuals, particularly those with declining autonomy, by enabling caregivers to monitor and manage their water intake effectively.

Cypheme is a company that specializes in counterfeit detection through its innovative application, which leverages artificial intelligence and machine learning. The application enables users to identify counterfeit products by analyzing the micro-structure of product packaging using only a smartphone camera. By employing advanced pattern recognition techniques, Cypheme's technology allows consumers to verify the authenticity of various products easily and efficiently. This approach not only helps in combating counterfeit goods but also enhances consumer trust in product quality and safety.

Founded in 2014 through a collaboration between experts from the Langevin Institute and Georges Pompidou Hospital, Cardiawave develops non-invasive ultrasonic medical devices for treating heart valve diseases. Its flagship product uses real-time imaging and ultrasound technology to treat conditions like calcified aortic stenosis without thermal injury or invasive procedures.

BibeliB is a brand of smart and trendy travel accessories. They created the first smart suit case. This suitcase bag is equipped with e an integrated traceability and insurance system. Thanks to our My BibeliB Paris app your suitcase cover is now connected to geolocate your suitcase and activate it more easily.

Medicapp Connect S.A.S. is a company based in Paris, France, that specializes in designing and developing healthcare software solutions. Founded in 2011, it focuses on creating applications for managing healthcare data, particularly through its flagship product, Medicapp EHR. This mobile application allows healthcare professionals to efficiently manage patient health records, documents, photos, and notes. By providing tools for the creation, classification, and communication of patient records, Medicapp Connect aims to streamline recordkeeping for healthcare providers, including physiotherapists, enhancing their ability to deliver care effectively.

Ensweet is a telemedicine platform specializing in telerehabilitation services aimed at enhancing patient accessibility to rehabilitation care. The company provides a range of equipment, including heart rate sensors and physical activity tools, allowing patients to engage in exercise regardless of their circumstances. This innovative approach ensures that rehabilitation is accessible to all, promoting healthier lifestyles and improved recovery outcomes for individuals in need of rehabilitation services.